Minimising activity and dose with enhanced image quality by radiopharmaceutical administrations
(2010) In Radiation Protection Dosimetry 139(1-3). p.250-253- Abstract
- Owing to the introduction of new diagnostic procedures, such as computed tomography (CT), positron emission tomography (PET) and single photon emission computed tomography (SPECT), the individual dose caused by medical exposures has grown rapidly in the last years. This is especially a subject to radiation protection for nuclear medical diagnosis, since in this case radiopharmaceuticals are administered to the patient, meaning not only a radiation exposure to the diseased tissue but also to the healthy tissues of large parts of the body. 'Minimizing Activity and Dose with Enhanced Image quality by Radiopharmaceutical Administrations' (MADEIRA) is a project cofunded by the European Commission within the Seventh Euratom Framework Programme... (More)
- Owing to the introduction of new diagnostic procedures, such as computed tomography (CT), positron emission tomography (PET) and single photon emission computed tomography (SPECT), the individual dose caused by medical exposures has grown rapidly in the last years. This is especially a subject to radiation protection for nuclear medical diagnosis, since in this case radiopharmaceuticals are administered to the patient, meaning not only a radiation exposure to the diseased tissue but also to the healthy tissues of large parts of the body. 'Minimizing Activity and Dose with Enhanced Image quality by Radiopharmaceutical Administrations' (MADEIRA) is a project cofunded by the European Commission within the Seventh Euratom Framework Programme that aims to improve three-dimensional (3D) nuclear medical imaging technologies significantly. MADEIRA is aiming to improve the efficacy and safety of 3D PET and SPECT functional imaging by optimising the spatial resolution and the signal-to-noise ratio, improving the knowledge of the temporal variation of the radiopharmaceuticals' uptake in and clearance from tumourous and healthy tissues, and evaluation of the corresponding patient dose. Using an optimised imaging procedure that improves the information gained per unit administered dose, MADEIRA aims especially to reduce the dose to healthy tissues of the patient. In this paper, an overall summary of the current achievements will be presented. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1617257
- author
- Hoeschen, C. ; Mattsson, Sören LU ; Cantone, M. C. ; Mikuz, M. ; Lacasta, C. ; Ebel, G. ; Clinthorne, N. and Giussani, A.
- organization
- publishing date
- 2010
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Radiation Protection Dosimetry
- volume
- 139
- issue
- 1-3
- pages
- 250 - 253
- publisher
- Oxford University Press
- external identifiers
-
- wos:000277738200045
- scopus:77953338210
- pmid:20228050
- ISSN
- 1742-3406
- DOI
- 10.1093/rpd/ncq104
- language
- English
- LU publication?
- yes
- id
- 3e0a85c7-4252-440b-8ac1-3a7ca3757a1f (old id 1617257)
- date added to LUP
- 2016-04-01 14:56:50
- date last changed
- 2022-01-28 03:15:38
@article{3e0a85c7-4252-440b-8ac1-3a7ca3757a1f,
abstract = {{Owing to the introduction of new diagnostic procedures, such as computed tomography (CT), positron emission tomography (PET) and single photon emission computed tomography (SPECT), the individual dose caused by medical exposures has grown rapidly in the last years. This is especially a subject to radiation protection for nuclear medical diagnosis, since in this case radiopharmaceuticals are administered to the patient, meaning not only a radiation exposure to the diseased tissue but also to the healthy tissues of large parts of the body. 'Minimizing Activity and Dose with Enhanced Image quality by Radiopharmaceutical Administrations' (MADEIRA) is a project cofunded by the European Commission within the Seventh Euratom Framework Programme that aims to improve three-dimensional (3D) nuclear medical imaging technologies significantly. MADEIRA is aiming to improve the efficacy and safety of 3D PET and SPECT functional imaging by optimising the spatial resolution and the signal-to-noise ratio, improving the knowledge of the temporal variation of the radiopharmaceuticals' uptake in and clearance from tumourous and healthy tissues, and evaluation of the corresponding patient dose. Using an optimised imaging procedure that improves the information gained per unit administered dose, MADEIRA aims especially to reduce the dose to healthy tissues of the patient. In this paper, an overall summary of the current achievements will be presented.}},
author = {{Hoeschen, C. and Mattsson, Sören and Cantone, M. C. and Mikuz, M. and Lacasta, C. and Ebel, G. and Clinthorne, N. and Giussani, A.}},
issn = {{1742-3406}},
language = {{eng}},
number = {{1-3}},
pages = {{250--253}},
publisher = {{Oxford University Press}},
series = {{Radiation Protection Dosimetry}},
title = {{Minimising activity and dose with enhanced image quality by radiopharmaceutical administrations}},
url = {{http://dx.doi.org/10.1093/rpd/ncq104}},
doi = {{10.1093/rpd/ncq104}},
volume = {{139}},
year = {{2010}},
}